Microbes in pharmaceutical industry

Divya Kapoor, Pankaj Sharma, Mayur Mukut Murlidhar Sharma, Anju Kumari, Rakesh Kumar*

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review


Microbes are ubiquitous in nature, and the tremendous potential of microbes is an unquestionable and unhidden phenomenon. The pharmaceutical aspects of microbial diversity can be judiciously explored for patronizing and safeguarding human health standards. Several studies have unveiled the remarkable wonders which target to prolong and ease the human health by treating pathogenic diseases and by curing different metabolic disorders, thereby sustaining human regime. Generally, the aim of pharmaceutical microbiology is to offer acquaintance and consider the importance of the occurrence of bacteria, yeasts, moulds, viruses and toxins in diverse pharmacological raw materials, products, intermediates and the environs advocating therapeutic construction as well as the microbial regulator of medicinal harvests, manufacturing surroundings and people. Meanwhile, the outline of this functional theme area of microbiology, above the ages, pharmacological microbiology, has advanced and stretched expressively to comprehend numerous other sides, e.g. examination and expansion of novel anti-infective representatives, the use of microbes to perceive mutagenic and oncogenic prospective in medications and the usage of microbes in the production of insulin and various other human growth hormone. An array of bioactive composites sequestered using different approaches have not only exposed prominence in diverse pharmaceutical and biotechnological solicitations but have also augmented the indulgence of mankind in exploring variety of microbiota and targeting their diverse functions and the credulous biology behind their production. The defensible and pecuniary stream of the dynamic pharmaceutical elements is often calmer to accomplish for composites fashioned through microbial fermentation attitudes versus the gardening of slower developing macroorganisms. This article stresses on microbial fabricators and their potential to engender innovative biologically active compounds and their starring role in the simplification of human life.

Original languageEnglish
Title of host publicationMicrobial Diversity, Interventions and Scope
PublisherSpringer Singapore
Number of pages41
ISBN (Electronic)9789811540998
ISBN (Print)9789811540981
StatePublished - 1 Jan 2020
Externally publishedYes


  • Antibiotics
  • Bacteriocins
  • Biosurfactants
  • Nutraceuticals
  • Therapeutic


Dive into the research topics of 'Microbes in pharmaceutical industry'. Together they form a unique fingerprint.

Cite this